Susan D. DeVore
CIK 1587697 · Chief Executive Officer · last filed 2026-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$32.96M
Companies
6
Total Filings
42
Lifetime Open-Market Net
-$4.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNMA | Director | 31,785 | $21.46 | $682.1K | -$808.8K | 9 | 2026-05-28 |
| SOLV | Director | 8,947 | $86.17 | $771.0K | $0 | 6 | 2026-05-18 |
| ELV | Director | 4,065 | $385.73 | $1.57M | $374.6K | 5 | 2026-05-15 |
| Elevance Health, Inc. (ANTM) Delisted | Director | 856 | $482.58 | $413.1K | $0 | 2 | 2022-05-20 |
| PINC | Chief Executive Officer | 590,001 | $50.05 | $29.53M | -$3.61M | 17 | 2020-08-27 |
| UNM | Director | 4,626 | $87.93 | $406.8K | $0 | 2 | 2018-05-29 |
Recent Filings · Page 2 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-04 | UNMA | Sell (S) | −10,000 | -$808.8K | EDGAR |
| 2025-03-03 | UNM | Notice (144) | −10,000 | -$808.8K | EDGAR |
| 2024-05-28 | UNMA | Grant (A) | +3,342 | $0 | EDGAR |
| 2024-05-17 | ELV | Grant (A) | +388 | $0 | EDGAR |
| 2024-05-15 | SOLV | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | UNMA | Grant (A) | +3,839 | $0 | EDGAR |
| 2023-05-12 | ELV | Grant (A) | +457 | $0 | EDGAR |
| 2022-05-31 | UNMA | Grant (A) | +4,448 | $0 | EDGAR |
| 2022-05-20 | Elevance Health, Inc. (ANTM) Delisted | Grant (A) | +440 | $0 | EDGAR |
| 2021-09-03 | Elevance Health, Inc. (ANTM) Delisted | Grant (A) | +416 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.